FDA Inspection 1198364 — Centaur Pharmaceuticals Private Ltd.

Centaur Pharmaceuticals Private Ltd. — FEI 3008861619

The FDA completed an inspection of Centaur Pharmaceuticals Private Ltd. on Feb 8, 2023 in Pune. The inspection was classified OAI (Official Action Indicated — regulatory and/or administrative actions are recommended). Product area: Drugs.

Inspection Details

Classification
Official Action Indicated (OAI)
End Date
Feb 8, 2023
Fiscal Year
2023
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Pune (India)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.